Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-25-000261·ENANTA PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Enanta Pharmaceuticals Inc
Common Stock · CUSIP: 29251M106
Event date: 2025-10-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 3,494,068 · Class: 12.1%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 2,959,525 · Class: 10.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000261
- Form type
- SCHEDULE 13G
- Filer
- ENANTA PHARMACEUTICALS INC
- CIK
- CIK 1177648
- Filed
- Nov 07, 2025
- Reporting period
- Oct 31, 2025
- Description
- Schedule 13G beneficial ownership